Full Report

The numbers behind PT Charoen Pokphand Indonesia Tbk: as-reported financial statements and company metrics for FY2021–FY2025, traced to the source filings, opened with the share-price history those statements have to justify. Every linked figure opens the exact page of the filing it was printed on, with the statement row highlighted. Amounts in Rp million unless noted.

Reading notes: All figures are consolidated and expressed in millions of Rupiah, exactly as printed in the audited/interim consolidated financial statements (Indonesian filings use '.' as the thousands separator). Citation filings: FY2025 = 2025 Annual Report (audited FS, p.76–83, segment Note 36 p.191, EPS Note 33 p.180); FY2024 = 2024 Annual Report (audited FS, p.117–123, EPS on face p.121); FY2023 = 2024 Annual Report comparative column (its own 2023 annual report contains only summarized MD A statements); FY2022 = FY2023 audited consolidated statements (year ended 31 Dec 2023) comparative column and Note 36 segment reconciliation. FY2022 income-statement detail (cost of goods sold, gross profit, operating-expense lines) could not be linked: the FY2022 statement of profit or loss is printed only as an image (no text layer) in the FY2023 audited statements, so only net sales, operating profit, finance costs, pre-tax profit, tax, net profit and EPS — which are reproduced as text in the segment-note reconciliation and changes-in-equity statement — are cited; other FY2022 cells are left blank. FY2021 figures are from the standardized data feed and are shown without page links (no FY2021 audited statements are in the corpus); FY2021 total equity is the one exception, cited to the FY2023 changes-in-equity statement opening balance.

The stock closed at IDR 3,070 on Jul 15, 2026 — down 31% over the window shown, trading between IDR 3,060 and IDR 4,530.

Source: market price feed, daily closes, Jan 2026–Jul 2026 — the feed marks this available history as partial. Price return only, excludes dividends.

FY2025 at a Glance

Revenue (Rp million)

70,704,988

Operating income (Rp million)

8,133,111

Net income (Rp million)

5,643,630

Source: FY2025 consolidated statements [1] [2] [3] [4]. Click any linked figure to open the filing page with the row highlighted.

Net Sales by Business Segment (External)

Net Sales by Business Segment (External)	FY2021	FY2022	FY2023	FY2024	FY2025
Feed	14,259,774	13,622,896	16,520,788	16,445,051	20,987,951
Broiler	26,901,030	31,966,248	31,732,809	35,319,774	34,027,549
Day-old chicks	2,142,996	1,477,885	1,821,425	2,502,496	3,455,378
Processed chicken	6,937,441	8,364,668	10,011,620	11,944,927	10,934,615
Others	1,457,008	1,435,847	1,529,208	1,265,744	1,299,495
Total net sales	51,698,249	56,867,544	61,615,850	67,477,992	70,704,988

Source: Note 36 — Segment Information (external sales); FY2021 from standardized data feed [5] [2] [6] [7]. Click any linked figure to open the filing page with the row highlighted.

Segment Results (Operating Profit by Segment)

Segment Results (Operating Profit by Segment)	FY2021	FY2022	FY2023	FY2024	FY2025
Feed	—	3,333,384	4,113,436	3,978,512	3,838,387
Broiler	—	(315,802)	(420,300)	2,031,538	3,349,806
Day-old chicks	—	183,558	(301,560)	461,487	648,594
Processed chicken	—	997,331	580,270	(81,829)	862,071
Others	—	(12,627)	(7,060)	(116,224)	(121,276)
Total segment results	—	4,185,844	3,964,786	6,273,484	8,577,582

Source: Note 36 — Segment Information (segment results = allocated revenue less allocated cost of sales and operating expenses) [5] [2] [6] [7]. Click any linked figure to open the filing page with the row highlighted.

Income Statement

Source: Consolidated Statement of Profit or Loss and Other Comprehensive Income; FY2022 detail from FY2023 segment-note reconciliation; FY2021 from data feed [1] [2] [3] [4]. Click any linked figure to open the filing page with the row highlighted.

Columns marked E are consensus analyst estimates shown alongside reported results for direct comparison; they are not company guidance.

Estimate source: analyst consensus (claude_web), as of 2026-07-16. Forecasts carry no filing page links.

Balance Sheet

Source: Consolidated Statement of Financial Position (year-end); FY2021 total equity from FY2023 changes-in-equity statement; other FY2021 lines from data feed [3] [8] [9] [10]. Click any linked figure to open the filing page with the row highlighted.

Cash Flow

Source: Consolidated Statement of Cash Flows; FY2021 from data feed [11] [12] [13] [14]. Click any linked figure to open the filing page with the row highlighted.

Long-Term Record (Rp million)

Fiscal year	Total revenue	Operating profit	Net profit attributable to owners	Basic earnings per share (Rupiah)	Operating cash flow	Total equity
FY2016	38,256,857	4,417,116	2,220,561	135	4,157,137	14,157,243
FY2017	49,367,386	3,716,274	2,497,765	152	1,624,465	15,702,825
FY2018	53,957,604	6,488,206	4,554,391	278	5,035,954	19,391,174
FY2019	58,634,502	4,932,919	3,634,620	222	3,400,173	21,071,600
FY2020	42,518,782	5,137,882	3,842,083	234	4,845,575	23,349,683
FY2021	51,698,249	4,934,364	3,620,961	221	2,121,905	25,149,999
FY2022	56,867,544	3,984,400	2,928,342	179	1,673,887	26,327,214
FY2023	61,615,850	3,654,606	2,318,584	141	3,146,254	27,028,758
FY2024	67,477,992	5,987,419	3,712,926	226	4,305,814	30,288,922
FY2025	70,704,988	8,133,111	5,643,863	344	5,773,901	34,151,094

Source: consolidated statements across filings; older years from the standardized feed [2] [12] [3] [8]. Click any linked figure to open the filing page with the row highlighted.

Analyst Consensus

Mean target

4,995.00

Street ratings: Consensus: Buy. 11 analysts — 7 Strong Buy, 2 Buy, 1 Hold, 0 Sell, 1 Strong Sell (StockAnalysis). Mean 12-month price target ~Rp 4,995 (range Rp 2,600–6,200), implying ~+60% upside. Other aggregators cite means of Rp 5,085–5,420 across 8–11 analysts, all rating Buy. All figures in IDR.

Estimate source: analyst consensus (claude_web), as of 2026-07-16. Forecasts carry no filing page links.

Traceability

243 of 298 figures on this page (82%) link to the filing page where they are printed — click a linked figure to open the source PDF at that page with the row highlighted. Unlinked figures come from standardized data feeds or pre-filing years.

All figures are consolidated and expressed in millions of Rupiah, exactly as printed in the audited/interim consolidated financial statements (Indonesian filings use '.' as the thousands separator).
Citation filings: FY2025 = 2025 Annual Report (audited FS, p.76–83, segment Note 36 p.191, EPS Note 33 p.180); FY2024 = 2024 Annual Report (audited FS, p.117–123, EPS on face p.121); FY2023 = 2024 Annual Report comparative column (its own 2023 annual report contains only summarized MD A statements); FY2022 = FY2023 audited consolidated statements (year ended 31 Dec 2023) comparative column and Note 36 segment reconciliation.
FY2022 income-statement detail (cost of goods sold, gross profit, operating-expense lines) could not be linked: the FY2022 statement of profit or loss is printed only as an image (no text layer) in the FY2023 audited statements, so only net sales, operating profit, finance costs, pre-tax profit, tax, net profit and EPS — which are reproduced as text in the segment-note reconciliation and changes-in-equity statement — are cited; other FY2022 cells are left blank.
FY2021 figures are from the standardized data feed and are shown without page links (no FY2021 audited statements are in the corpus); FY2021 total equity is the one exception, cited to the FY2023 changes-in-equity statement opening balance.
FY2016–FY2020 long-term figures are from the standardized data feed (as reported) and are shown without page links.
Revenue mix: broiler is the largest segment; the sharp FY2020 step-down in external feed sales versus FY2019 reflects more feed being consumed internally by the (rapidly growing) broiler segment rather than sold externally — the total reconciles to reported net sales every year.
Quarterly income and cash-flow single quarters are DERIVED from the printed year-to-date interim statements (Indonesian interim filings present cumulative figures only); each derived cell links to the filing's year-to-date row (anchor = printed YTD figure) and every derived quarter reconciles exactly to the audited full-year total. Quarterly balance-sheet figures are point-in-time as printed. No share split occurred in the quarterly window (eps_split_adjusted=false).
Long-term caution (FY2019 vs FY2020): the FY2020 audited financial statements restated FY2019 comparatives, reclassifying a large block of broiler revenue on a net basis (FY2019 net sales reduced by ~Rp16tn). The unlinked FY2016–FY2019 feed figures shown here are on the as-originally-reported basis, so the FY2019→FY2020 step-down overstates the true year-on-year change; FY2020 onward is on the current (restated) basis and is internally consistent.

PT Charoen Pokphand Indonesia Tbk's annual reports contain management's most considered account of the business. These are the sections, passages and visual pages worth opening in the originals preserved in Sources.

PT Charoen Pokphand Indonesia Tbk — 2025 Annual Report — FY2025

Latest report; management explains a year where feed and DOC grew strongly while broiler priced down but margins recovered. · Open the full document →

Directors' Report (Laporan Direksi) — p. 4 · Read the full section →

Management's own segment-by-segment account of what drove 2025 — the clearest read on how each part of the poultry chain performed.

Segment scorecard: feed +27.62%, broiler down modestly but rebalanced, DOC +38.08%.

The feed business recorded steady growth during the year, with sales increasing by 27.62%. […] Although sales in the commercial chicken segment experienced a modest decline of 3.66% for the year, the overall market remained well-balanced, with supply and demand moving into closer alignment. […] The DOC segment recorded a strong year, with sales increasing by 38.08%.

p. 4 · Read in context →

Corporate Identity & Brief History — p. 11 · Read the full section →

The founding, charter and mission — a poultry-feed company since 1972 built to "feed a growing world."

Business Segment Outlook — p. 24 · Read the full section →

How the company actually makes money: the feed brands, the broiler grow-out cycle, and each segment's sales moves.

Feed brands and the broiler grow-out cycle behind the revenue.

The Company has developed leading brands in the feed industry, such as HI-PRO, HI-PRO-VITE, BINTANG, BONAVITE, ROYAL FEED, TURBO FEED and TIJI. […] Net sales of poultry feed increased by Rp4.54 trillion or 27,62% from Rp16.45 trillion in 2024 to Rp20.29 trillion in 2025. […] Broilers are raised for approximately 30 - 45 days before being harvested at an average weight of 1.39 kg - 2.45 kg and yield around 1.11 kg - 1.96 kg of poultry meat.

p. 25 · Read in context →

Financial Performance Analysis (MD&A) — p. 27 · Read the full section →

Management ties the balance-sheet movement to the operating story — where the year's growth in assets came from.

Risk Management System — Business Risks — p. 56 · Read the full section →

The two risks specific to this business that can genuinely bite: corn/soybean input-price swings and poultry disease outbreaks.

Valuation of Biological Assets (Accounting Policy) — p. 131 · Read the full section →

A policy that defines the livestock business model: growing flocks and hatching eggs carried at fair value, breeder flocks at depreciated cost.

Living inventory measurement: fair-value-less-cost-to-sell vs. cost-less-depletion.

Growing flock and hatching eggs are measured at fair value less costs to sell. While breeding flock which fair values cannot be measured reliably are stated at costs less accumulated depletion and accumulated impairment losses.

p. 131 · Read in context →

More annual reports

PT Charoen Pokphand Indonesia Tbk — 2024 Annual Report — FY2024 · 245 pages · Prior-year edition; same segment structure, useful baseline for the 2025 feed vs. broiler swing. · Open →

PT Charoen Pokphand Indonesia Tbk — 2023 Annual Report — FY2023 · 67 pages · Covers a weaker margin year for the poultry cycle. · Open →

PT Charoen Pokphand Indonesia Tbk — 2022 Annual Report — FY2022 · 65 pages · Post-pandemic recovery year with elevated raw-material costs. · Open →

PT Charoen Pokphand Indonesia Tbk — 2021 Annual Report — FY2021 · 180 pages · Earliest edition on the shelf; fuller 180-page report for the pandemic-era baseline. · Open →

Competitors describe PT Charoen Pokphand Indonesia Tbk's market in their own filings and calls. These verified passages and visual pages show where their strategies meet, using source documents preserved in Sources.

PT Malindo Feedmill Tbk (MAIN)

A listed, vertically integrated Indonesian feed–DOC–broiler–processed-food producer and one of CPIN's most direct domestic competitors. Its investor decks explicitly map Indonesian feed and day-old-chick capacity share by player, placing CPIN ('CP') first — a rival's own quantification of the subject's market leadership.

On the same slide, Malindo positions itself as a top-5 integrated player in the Indonesian feed-to-broiler chain — implicitly behind CP and Japfa on the capacity-share charts above.

We are among the top 5 integrated players and well-positioned in the market supported by our strategic locations

p. 25 · Read in context →

Malindo's thesis on the Indonesian poultry market CPIN leads — poultry as the country's dominant and cheapest animal protein, with consumption rising as diets shift toward protein.

Poultry is a major source of animal protein for almost 90% of the country's non-pork eating population. […] More and more people shift from carbohydrate sources of food to proteins and poultry is the cheapest source of protein.

p. 24 · Read in context →

PT Widodo Makmur Unggas Tbk (WMUU)

A younger, smaller Indonesian integrated poultry player — feed, DOC, commercial broiler, layer and slaughtering — competing in the same domestic feed-to-food chain as CPIN. Useful for how a challenger frames the shared Indonesian protein-demand opportunity and its own ambitions against the incumbent leader.

Widodo Makmur Unggas's read on the demand pool it shares with CPIN — a growing Indonesian middle class (47.85 million people) and a young, productive-age population driving rising poultry-meat consumption.

The growing middle class segment will be the main driver of the increase in poultry meat consumption in Indonesia, where there are 47,85 million Indonesians (17,13% of the total population) who fall into the middle class segment. Indonesia's productive age population (15-64 years old) accounts for almost three quarters of the total population. This segment of the population is the driving force behind new food trends and cuisines, thus supporting the F&B industry and the related meat industry.

p. 131 · Read in context →

Charoen Pokphand Foods PCL (CPF)

The CP group's Thailand-listed agrifood flagship and the standard large-cap comparable for CPIN, running an identical integrated feed–breeding–farming–processing–food model across 17 countries. It is an affiliate within the wider Charoen Pokphand group rather than a head-to-head Indonesian rival, but its filings are the clearest window onto the global protein market and CP operating model within which CPIN sits.

CPF describes the same vertically integrated model CPIN runs — feed production, breeding, farming, processing and food — across the core livestock categories of swine, broiler, shrimp and layer, establishing it as CPIN's closest business-model comparable.

The Company operates an agro-industrial and food business focusing on animal protein products, with its key livestock categories comprising swine, broiler, shrimp, and layer. Its business model covers feed production, animal breeding, […] primary processing, food production and ready-to-eat meals, as well as the trading of meat and food products, restaurant operations, and the production and distribution of pet treats.

p. 17 · Read in context →

CPF's own 'Marketing and competition' review sizes the global broiler market (~107.6 million tons in 2025) and ranks Thailand the world's fourth-largest exporter — the international poultry-market backdrop for CPIN's Indonesian operations.

In 2025, global broiler production reached 107.6 million tons, an increase from 2024 (104.2 million tons). […] Thailand ranked as the world’s fourth-largest broiler exporter, with an export volume of approximately 1.25 million tons, representing an increase of 6.8% compared to 2024.

p. 36 · Read in context →

The business, and the cycle it turns on

PT Charoen Pokphand Indonesia (IDX: CPIN) is Indonesia's largest integrated poultry producer, running the full chain from feed milling and breeding through broiler farming to processed food [1]. FY2025 was a record: net profit rose 52% to Rp5.6 trillion on 4.8% revenue growth [2]. But the gain came almost entirely from a recovery in broiler and processed-chicken margins — the cyclical, price-taking end of the chain — while the shares have fallen about a third from their January 2026 high.

What CPIN is

Founded in 1972 as an animal-feed miller and listed on the Jakarta exchange, CPIN has built the widest vertical integration in Indonesian protein: it mills poultry feed, hatches day-old chicks, raises broilers on its own and partner farms, slaughters and processes, and sells branded chicken products through its own retail formats [3]. It carries 16,398,000,000 shares of Rp10 par value [4]. At the 15 July 2026 close of Rp3,070, that is a market value near Rp50 trillion.

FY2025 Revenue (Rp tn)

70.7

FY2025 Net Profit (Rp tn)

5.64

Operating Margin

11.5%

Return on Equity

16.5%

Market Cap (Rp tn)

50.3

P/E (FY2025 EPS)

8.9

Sources: FY2025 revenue, profit and margin per the FY2025 Annual Report, 2025 Performance [5]; market cap and P/E derived from the 16,398,000,000 share count [6] and the IDX closing price of Rp3,070 on 15 July 2026.

By reported revenue, CPIN looks like a broiler company: fresh broiler chicken was 48% of FY2025 external sales, feed 30%, processed chicken 15%, and day-old chicks 5% [7]. Where the money is made tells a different story.

How it makes money

Feed is the durable earner; the downstream is the swing factor. In FY2024 — a weaker year — feed generated Rp3.98 trillion of segment result, 63% of the group's Rp6.27 trillion total, while processed chicken lost Rp82 billion [8]. In FY2025 the feed result actually eased slightly to Rp3.84 trillion, but broiler profit rose two-thirds to Rp3.35 trillion and processed chicken swung to a Rp862 billion profit, lifting the total segment result to Rp8.58 trillion [9].

Source: segment results (Hasil segmen) per Note 36 of the FY2024 [10] and FY2025 [11] audited financial statements.

The mechanism is integration. Feed is sold both to independent farmers and internally to CPIN's own broiler and breeding operations, so its margin is comparatively steady across the cycle. Broiler and day-old chicks are price-takers: their profitability is the spread between live-bird and chick prices — set by Indonesian supply-demand — and feed cost, which is dominated by imported corn and soybean meal. When that spread widens, as it did in FY2025, the downstream produces most of the incremental profit; when it narrows, feed carries the company. Management's own account of the record year is consistent with this: the FY2025 gross-profit gain came chiefly from broiler and processed chicken, even though those lines' external revenue fell, offset by feed and day-old-chick volume growth [12].

The cycle in the numbers

Revenue has climbed steadily — a 7.6% compound rate over FY2022–FY2025 — but profit has not. Net profit fell three years running from Rp3.62 trillion in FY2021 to Rp2.32 trillion in FY2023, then nearly tripled off that trough to Rp5.64 trillion by FY2025 [13] [14]. Operating margin traces the same arc: 9.5% in FY2021, down to 5.9% in FY2023, back to 11.5% in FY2025.

Source: FY2021 figures per FY2021 Annual Report highlights [15]; FY2023–FY2024 per FY2024 Annual Report income statement [16]; FY2025 per FY2025 Annual Report [17]. FY2022 net profit of Rp2.93 trillion is from the audited FY2022 statements.

Source: derived from reported operating profit and net sales, FY2021–FY2025 audited financial statements.

That volatility sits on top of an unusually conservative balance sheet. Equity of Rp34.2 trillion funds roughly 74% of the Rp45.9 trillion asset base [18] [19]. Bank borrowings total about Rp6.3 trillion — Rp3.5 trillion short-term and Rp2.8 trillion long-term [20] [21] — against Rp4.5 trillion of cash [22], leaving net leverage negligible relative to equity. The company distributed Rp108 per share on FY2024 earnings — Rp1.77 trillion, roughly 48% of profit — paid in June 2025, up from Rp30 the year before [23]. The low leverage is what lets a price-taker absorb a two-to-three-year earnings trough without financial stress — and keep paying dividends through it.

The stock against the record

The market has not treated FY2025 as a new baseline. The shares peaked near Rp4,530 in January 2026 and closed at Rp3,070 on 15 July, a decline of about a third, even as the company reported its best-ever profit and carried early-FY2026 momentum.

Source: IDX daily closing prices, January–July 2026, as reported.

At Rp3,070, CPIN trades at about 8.9 times its record FY2025 earnings of Rp344 per share and yields roughly 3.5% on the last dividend. That is not the multiple of a business the market expects to hold this level of profit. The de-rating is the reader's first clue that the debate here is about durability, not disclosure.

The question this report is built to answer: is CPIN's record FY2025 the durable earning power of Indonesia's dominant poultry integrator, or the peak of a cycle — one powered by a broiler-and-processed-chicken margin recovery that the feed business stabilizes but does not control, and that the market, with the shares down about a third from their January 2026 high, is already discounting? What follows tests each part of that question in turn — the economics of the integration, what drives the spread the downstream lives on, how the balance sheet and management behave across the cycle, and what the price now implies.

Feed Economics

The feed mill is the part of CPIN a casual reader underweights. On the group's revenue line, feed is only 30% of external sales; inside the segment note it is a Rp52.2 trillion operation — the largest by throughput, most of it consumed by CPIN's own farms. Its segment result has sat in a narrow Rp3.3–4.1 trillion band for six years while the downstream swung from a loss to a record. Feed is the keel that lets the company survive its own cycle — but the same numbers show it does not set the upside.

The engine most of the group's revenue hides

The reported segment mix understates feed twice over. What reaches the top line as "feed" is only the Rp21.0 trillion sold to third-party and plasma farmers [1]. Add the Rp31.2 trillion of feed transferred internally to CPIN's own broiler and day-old-chick operations and total feed throughput was Rp52.2 trillion in FY2025 — larger than the broiler segment and roughly three-quarters of consolidated revenue in volume terms [2].

Feed Throughput FY2025 (Rp tn)

52.2

Consumed Internally

60%

Feed Segment Result (Rp tn)

3.84

Feed % of Group Result

45%

Source: FY2025 Consolidated Financial Statements, Note 36 [3].

That 60% internal share is the first reason feed earns steadily: roughly Rp31 trillion of its annual output goes to CPIN's own chicken farms, which must be fed whatever the broiler price is doing. The mill runs against captive demand that the cycle cannot switch off, and the remaining ~40% is sold at market to independent and plasma farmers. Feed segment assets of Rp22.8 trillion are the single largest block on the balance sheet — 51% of allocated segment assets — so this is a capital-heavy business, but one whose volume base is unusually protected [4].

The keel and the sail

Feed's segment result — allocated revenue less allocated cost of goods sold and operating expenses [5] — has barely moved across the cycle. It was Rp3.91 trillion in FY2020, Rp3.58 trillion in FY2021 [6], Rp3.33 trillion in FY2022 [7], then Rp4.11 trillion, Rp3.98 trillion and Rp3.84 trillion in FY2023–FY2025 [8] [9]. Six years, a band of roughly Rp3.3–4.1 trillion, no year of loss.

The downstream — broiler, day-old chick and processed chicken combined — did the opposite.

Downstream = broiler + day-old chick + processed chicken segment results. Source: FY2023 and FY2025 Consolidated Financial Statements, segment notes [10] [11].

FY2023 is the year the structure shows through cleanest. The three downstream segments together lost Rp142 billion — broiler down Rp420 billion, day-old chicks down Rp302 billion, only processed chicken positive [12]. Feed earned Rp4.11 trillion, which was 104% of the group's entire segment result. In its worst downstream year of the cycle, the company's profit was the feed business, and everything else was a drag. That is what "durable earner" means in cash terms, not adjective terms.

Feed steadies; the downstream sets the swing

Put the two on a margin basis and the division of labour is unmistakable. Feed's result margin — on total segment sales including internal transfers — held between 7.4% and 8.3% every year. The broiler margin ran from minus 1.1% to plus 8.3% over the same four years.

Result margin = segment result ÷ total segment sales (external plus inter-segment). Source: FY2023 and FY2025 segment notes [13] [14].

The full segment table makes the point at the level of rupiah. Note the last column: feed's share of group result falls not because feed weakens but because the downstream recovers into it.

No Results

Feed total sales include inter-segment transfers. Source: FY2023 and FY2025 Consolidated Financial Statements, segment notes [15] [16].

Why the mill holds when the farm does not

Feed's raw material is the same commodity risk everyone in poultry carries: corn and soybean meal are, in management's own words, "a substantial component of feed's raw material cost", their prices set by weather, harvests and global supply [7]. The company imports the raw materials it cannot source locally — soybean meal especially, which has no meaningful domestic crop — so a shock like the 2022 spike in soybean-meal prices after the invasion of Ukraine feeds straight into cost [17]. Feed's stability is therefore not the absence of input volatility; it is the ability to pass that volatility through.

Two structural features make the pass-through work. First, pricing power over a fragmented buyer base: feed is sold in bags to tens of thousands of independent farmers who have no substitute at CPIN's scale and quality, so cost increases move into price with a lag rather than into margin permanently. Second, the company has spent the cycle shortening its own corn supply chain — sourcing from more than 21,000 plasma corn farmers through affiliate BISI International and building corn drying and storage next to its feed mills, which lowers transport cost and secures the largest single input [18] [10]. This is why feed dipped only modestly in the FY2021–FY2022 input squeeze — result fell from Rp3.91 trillion to Rp3.33 trillion, about 15%, and never turned negative [19] [20] — while the broiler business, a pure price-taker on live-bird prices, fell into loss.

The corn dependence is also the reason to watch feed rather than assume it: management flags that the poultry industry "is driven by cyclical factors, in particular, the availability and pricing of raw materials used in poultry feed" [7]. A domestic corn failure or a soybean-meal spike that outruns CPIN's ability to reprice would compress feed and the downstream at once — the one scenario in which the keel and the sail move the same way.

What feed does not do

The stabilizer reading has a hard limit, and FY2025 draws it. In the record year, feed's result did not lead — it fell, from Rp3.98 trillion to Rp3.84 trillion, and its share of group result dropped to 45% [21]. The extra Rp2.3 trillion of group segment result that made FY2025 a record was almost entirely downstream: broiler alone added Rp1.3 trillion and processed chicken swung from a Rp82 billion loss to a Rp862 billion profit [22]. Feed keeps the company solvent through the trough; it does not create the peak. That is the division the Business and Cycle chapter framed, now measured: the feed core stabilizes group profit, but the earning power the market is being asked to value is downstream and cyclical.

One caveat cuts against reading feed's steadiness too cleanly. Because ~60% of feed "sales" are internal transfers priced by CPIN itself, the split of profit between feed and broiler is partly an allocation choice, not purely an arm's-length market outcome [23]. If the company holds feed transfer prices firm while live-bird prices collapse, feed will look stable and broiler will absorb the hit by construction. The evidence that feed's stability is real, not just accounting geography, is the external channel: the ~40% of feed sold to independent farmers is priced at market, and that arm's-length feed business has stayed profitable through the same trough. The read to hold is that feed is a genuine cross-cycle earner; what would sharpen it is a year in which corn and soybean-meal costs spike and CPIN cannot reprice — the test feed has not yet failed, and the number to watch is the feed result margin holding its 7–8% band.

The downstream cycle

CPIN's record FY2025 and its fast start to 2026 were made in the part of the business it controls least. The broiler, day-old-chick and processed segments swung from a collective loss in FY2023 to Rp4.86 trillion of segment result in FY2025, taking their share of group profit from below zero to 57%, and to 71% in the first quarter of 2026. That swing — not feed — is what the record rests on, and it turns on a live-bird price, an industry supply balance and a demand policy that sit outside the company's hands.

The downstream swing

Feed is the steady base (Feed Economics); the downstream is the amplitude. In the FY2023 trough the broiler, DOC and processed segments together lost Rp142 billion, and the company's entire Rp3.96 trillion of segment result came from feed [1]. Two years later the same three segments earned Rp4.86 trillion, more than the whole group made in the trough, while feed eased to Rp3.84 trillion [2].

Sources: FY2023 [3], FY2024 [4] and FY2025 [5] segment notes (downstream = broiler + day-old chicks + processed chicken).

The broiler line alone shows how wide the amplitude runs. Its segment result has travelled from a Rp0.73 trillion profit in 2020 to a Rp1.27 trillion loss in 2021 [6], a narrower loss in 2022 [7], back to a loss in the FY2023 trough, and then to Rp2.03 trillion and Rp3.35 trillion of profit in the last two years. Feed's six-year range is roughly Rp3.3–4.1 trillion; broiler's is a Rp1.27 trillion loss to a Rp3.35 trillion profit.

Sources: broiler segment results per the FY2021 [8] and FY2022 [9] annual reports and the FY2023 [10] and FY2025 [11] segment notes.

What actually moved the downstream in FY2025

The record downstream year was not a broiler-price boom. The broiler segment's net sales actually fell 3.7% to Rp34.0 trillion because the average selling price of live birds declined over the year; the segment result nonetheless rose 64.9% to Rp3.35 trillion, which management attributes to improved production efficiency rather than price [12]. Processed chicken tells the same story from the other side: volume slipped, sales fell 8.5%, yet the segment turned a Rp0.08 trillion loss into a Rp0.86 trillion profit purely on lower cost of goods sold [13]. Only day-old chicks earned more on higher prices and volume together [14].

No Results

Sources: net sales and segment-result drivers per the FY2025 Annual Report, Business Segment Outlook and Financial Performance Analysis [15][16]; segment-result levels per the FY2025 segment note [17].

Two things follow. First, the downstream recovery was operating leverage, not pricing power — a lower live-bird price still produced record profit because birds were raised and processed more cheaply. Notably, that was not a feed-cost windfall: CPIN's own feed result eased 3.5% on higher raw-material prices in 2025 [18], so the downstream margin came from conversion efficiency and, in management's framing, a "more balanced supply-demand dynamic" across the industry [19]. Second, efficiency is a more durable source of profit than a spot-price spike — but the level of that profit still depends on where the industry spread sits, and that spread is set outside the company.

The levers CPIN does not set

Three forces move the downstream spread, and CPIN is a price-taker on all three.

The live-bird price. Broiler is a spot commodity; the FY2025 result shows the company earning through a falling price, but it cannot lift that price. When the industry floods — as it chronically does — the live-bird price is the first thing to break, and the broiler segment is where the loss lands, as it did across 2021–2023.

Industry supply, which the government actively manages. Indonesia's broiler sector runs to structural oversupply, and the agriculture ministry intervenes directly to defend farm-gate prices — repeatedly ordering breeders to cull parent stock and cut hatching-egg production during price slumps, most visibly in 2020 and again in earlier cycles. That management cuts both ways for CPIN. As one of the three large integrators (with Japfa and Malindo) it is better placed than independent farmers to weather a slump, but the interventions also invite scrutiny: in 2016 the competition authority (KPPU) alleged the majors, CPIN among them, had colluded to cull breeders and prop up day-old-chick prices — the company's defence was that the culling had been government-ordered. The supply balance that "made" FY2025, in other words, is administered, contested, and reversible. (Industry and regulatory history from public reporting; not in the company's own filings — see manifest.)

Demand, now shaped by policy. The newest swing factor is fiscal: the Free Nutritious Meals (Makan Bergizi Gratis, or MBG) programme launched in 2025, which channels government spending into school meals with chicken and eggs as core protein, and which sell-side and news coverage repeatedly cite as a structural demand tailwind for CPIN [20]. It rests on the same demographics the company points to — poultry as Indonesia's cheapest animal protein, with per-capita consumption still well below regional norms [21]. A demand floor set by a government programme is a genuine support, but it is also a policy that a future budget can trim.

Where 2026 sits

The de-rating of about a third from the January 2026 high (Business and Cycle) reads, on the tape, as the market pricing the end of a favourable setup rather than a downturn already underway. The first quarter of 2026 was not soft: net profit rose about 67% to Rp2.58 trillion on higher chicken prices and volume [22], and the downstream supplied Rp2.47 trillion of the Rp3.51 trillion segment result — 71% of the total, its highest share in the record run [23].

Q1 2026 net profit (Rp tn)

2.58

YoY profit growth

67%

Downstream share of segment result

71%

Sources: Q1 2026 net profit and drivers per the news digest [24]; segment split per the Q1 FY2026 segment note [25].

The catch is what the first quarter contains. It captures the pre-Lebaran seasonal peak, when demand and prices are strongest; sell-side coverage of the same quarter pairs the strong print with an explicit expectation that prices normalise from that peak amid "lingering oversupply", weighing on average selling prices and segment margins later in the year. So the reading here is measured: the downstream that made the record is genuinely higher-quality profit than a price spike — it came from efficiency and held up as prices fell — but its level still depends on an industry spread the company cannot set, that the government periodically has to defend by culling, and that has flooded to losses twice in the past five years. The strongest fact against a bearish read is Q1 2026 itself: profit is still accelerating, and MBG puts a policy floor under demand that the last two down-cycles lacked. What would decide it is observable in the quarterly segment note and Indonesian farm-gate price data — a rebuild of day-old-chick placements and a fall in the live-bird price would mark the turn; their continued absence would say the FY2025 spread has legs.

Cash Conversion

Across the full FY2020–FY2025 cycle, CPIN turned essentially all of its reported profit into cash: cumulative operating cash flow of Rp21.9tn against Rp22.1tn of owners' profit, a conversion ratio of 0.99. But the timing is counter-cyclical — the heavy-investment years burned free cash while the profit trough threw it off — and the record FY2025 profit is flattered only modestly (about 6% of pre-tax) by a non-cash mark on biological assets. The dividend flexes with cash, not the earnings line.

OCF / Net Profit (FY20–25)

0.99

Free Cash Flow FY2025 (Rp tn)

4.07

Biological Assets / Total Assets

11.4%

FV Gain / Pre-tax Profit FY2025

6.1%

Source: derived from reported financials, FY2020–FY2025 audited statements [1]; biological assets [2].

The record profit is backed by cash

CPIN's FY2025 profit of Rp5.64tn was matched, not manufactured: operating cash flow was Rp5.77tn [3] [4], a 1.02 conversion of profit to cash in the record year. The direct-method statement shows why there is no receivables game behind the print: cash received from customers was Rp70.73tn against net sales of Rp70.70tn, so collections kept pace with the top line [5].

The steadier way to read cash quality in a cyclical business is across the whole cycle, and there the picture is clean: from FY2020 to FY2025, cumulative operating cash flow of Rp21.9tn covered 99% of the Rp22.1tn of profit attributable to owners. Over six years, reported earnings and cash are the same number.

Source: derived from reported financials, FY2020–FY2025 audited statements; FY2025 cash flow [6].

The chart also shows the catch, and it is a timing catch, not a quality one. In FY2021 and FY2022 operating cash flow ran well below profit — 0.59 and 0.57 of net income — because a growing business builds inventory and biological assets faster than it collects on them. In FY2023, the profit trough, the relationship inverted: cash flow of Rp3.15tn ran to 1.36 of a depressed Rp2.32tn profit as that working capital drained back out. Cash conversion is real, but it arrives on a different schedule than the income statement, and it is strongest exactly when reported profit is weakest.

Free cash flow disappears in the build years

The counter-cyclical timing is sharper once capital spending is netted off. CPIN spent Rp2.75tn and Rp2.53tn on fixed assets in FY2021 and FY2022 — against operating cash flow of Rp2.12tn and Rp1.67tn — so free cash flow was negative in both years, roughly −Rp0.63tn and −Rp0.86tn. The company funded that gap by drawing short-term bank debt, which is why the balance sheet's borrowings rose into the down-cycle rather than in the boom. As the cycle turned, capex fell to a Rp0.76tn trough in FY2024 and free cash flow swung to Rp3.54tn, then Rp4.07tn in FY2025 even as spending more than doubled back to Rp1.70tn [7].

Source: free cash flow derived from reported financials (OCF less capex), FY2020–FY2025; FY2025 cash flow [8]; dividends [9] [10].

The re-acceleration of capex is worth flagging as a watch item rather than a verdict: FY2025 fixed-asset spending of Rp1.70tn, plus land and breeding-facility purchases disclosed through the year, signals CPIN is adding capacity into a downstream that its own record year showed is priced by an externally-managed supply balance (Downstream Cycle). Capacity added at the top of a spread cycle earns its return only if demand — the government's Free Nutritious Meals programme prominent among the sources — grows into it.

Biological assets: the one number the auditor singles out

The accounting-quality question a skeptic raises first about a poultry integrator is the fair-value mark on live birds. CPIN carries biological assets — growing broilers, breeding flock and hatching eggs — at fair value less costs to sell, and the balance was Rp5.24tn at end-FY2025, or 11.4% of total assets [11]. It is the sole key audit matter in the FY2025 audit, flagged by the group's auditor (a member firm of Ernst & Young) as material and dependent on significant management estimates — day-old-chick selling prices, productivity, mortality and cultivation costs for the breeding flock [12]. A year earlier the same line was Rp4.71tn, which the auditor likewise put at 11% of consolidated assets [13].

The mark flows through the income statement on its own line, and it is pro-cyclical: a gain of Rp469bn in FY2025 and Rp294bn in FY2024, but a loss of Rp65bn in FY2023 [14] [15]. The swing helps in a good year and hurts in a bad one, on top of the operating spread it sits beside.

Source: consolidated statements of profit or loss, FY2023–FY2025 [16] [17].

The reassuring part is the size. The FY2025 fair-value gain of Rp469bn is 6.1% of pre-tax profit of Rp7.71tn — a real contribution to the record, but a minority one, and it is verified by the auditor against near-year-end sales invoices for the growing flock rather than modelled in the abstract [18]. This is not an earnings engine dressed up as a fair-value mark.

The genuine exposure is broader than the mark itself. Biological assets of Rp5.24tn plus inventories of Rp11.41tn are Rp16.65tn, or 36% of total assets, and both are valued on prices — chicken and feed — that move with the same cycle that drives the operating spread [19]. A downturn that compresses the live-bird spread would also press the carrying value of these two lines, so the same event shows up twice: once in the operating result and once in the fair-value and net-realisable-value adjustments. That is a feature of the accounting, honestly disclosed, not a manipulation — but it means reported profit amplifies the cycle in both directions.

Reported profit converts to cash across the cycle (six-year OCF/net-profit of 0.99), and the biological-asset fair-value gain is a modest 6% of FY2025 pre-tax profit — but 36% of assets sit in inventory and live birds valued on cyclical chicken and feed prices, so a downturn would hit both the operating result and these carrying values at once.

The dividend follows the cash, not the profit line

CPIN's payout history is the clearest evidence that management runs the business off cash and balance-sheet capacity rather than the reported-earnings line. For FY2022 — a year of Rp2.93tn reported profit but negative free cash flow and rising debt — the company paid no dividend at all, retaining the entire year's profit [20]. For FY2023 — the profit trough, but a year of recovered cash flow — it did the opposite, paying out roughly 92% of a depressed Rp2.32tn profit: a Rp100 interim in November 2023 and a Rp30 final, Rp130 per share and Rp2.13tn in total [21].

The recovery years then normalised the payout back toward half of earnings — Rp108 per share (Rp1.77tn) on FY2024 and Rp180 per share (Rp2.95tn, a 52.3% payout) on the record FY2025, the latter approved at the May 2026 annual meeting [22] [23].

No Results

Source: FY2022 nil dividend [24]; FY2023 and FY2025 dividends [25] [26]; cash dividends paid [27].

For an income-oriented reader, the implication is direct: this is a variable dividend, not a progressive one. The payout was zero as recently as FY2022 and could be again if a down-cycle coincides with a capex build. What the record does support is that the policy is disciplined rather than stretched — CPIN cut when cash was tight and paid generously when cash recovered, and the balance sheet that carried it through the FY2021–22 build (a conservative funding mix established in Business and Cycle) is why the dividend could be a shock absorber rather than a constraint. The FY2025 dividend of Rp2.95tn was covered 1.4 times by free cash flow of Rp4.07tn; the question for the next trough is whether capex plans leave that cushion intact.

Cash conversion confirms that the record earnings are real money, which raises rather than settles the through-line: the level of that cash is still set by the downstream spread, and the same cycle that lifts profit, free cash flow and the fair-value mark together would pull all three back down at once.

Competitive Moat

The through-line calls CPIN Indonesia's "dominant" integrator. That claim holds where it matters most and stops where the cycle is decided. CPIN controls roughly 35% of national feed and day-old-chick capacity — the largest share, and close to twice the number two — inside a four-firm oligopoly that accounts for about 95% of feed output. The scale converts into a real edge: an ~8% net margin against Malindo's ~3%, and an unbroken record of profit through a cycle that pushes weaker integrators to the wall. The moat is genuine in the feed-and-breeding base; it does not extend to the government-managed downstream spread, where scale buys resilience, not immunity.

A four-firm oligopoly, with CPIN on top

Indonesian poultry feed is not a fragmented market. On Malindo's own reckoning, 2025 national feed capacity splits between the CP group at 35%, Japfa (JPFA) at 22%, New Hope at 10%, Malindo (MAIN) itself at 8% and De Heus at 4% — leaving roughly a fifth to everyone else [1]. The day-old-chick (DOC) picture is the same shape: CP 35%, Japfa 28%, then a long tail [2]. An independent structure-conduct-performance study of the listed feed producers put the four-firm concentration ratio at about 96% over 2023–24 and the Herfindahl index firmly in oligopoly territory, with CPIN "the market leader and price leader" — its feed share rising to roughly 37.5% in 2024 from 35.6% a year earlier, per BRI Danareksa's read of the same data (industry SCP study, 2025; not in the filing corpus).

Source: PT Malindo Feedmill FY2025 Results Briefing, "How we see our markets" [3]; CP denotes the Charoen Pokphand group's Indonesian feed operations, of which CPIN is the listed vehicle.

Two features of that structure matter for an investor. First, it is stable — the ranking has barely moved quarter to quarter, and the smaller names (Malindo, Cibadak) have been losing share, not gaining it. Second, scale is the entry barrier: the study's minimum-efficient-scale estimate sat near 44% of the market, meaning a sub-scale mill cannot reach the unit costs of the leaders. Feed is a business of drying, milling and formulating bulk grain at razor spreads; the firm that runs the most tonnage over the most fixed assets wins on cost. CPIN runs the most tonnage.

What the scale is built on

CPIN's lead is not a single plant advantage but the depth of the integration behind it. The feed operation is a Rp52 trillion throughput business once internal transfers are counted, roughly 60% of it consumed by the company's own farms rather than sold — captive demand the cycle cannot switch off (Feed Economics). That volume is fed by a raw-material supply chain competitors cannot easily replicate: a corn-partnership network of more than 21,000 plasma farmers sourced through affiliate BISI, with drying and storage sited next to the mills, plus a "closed house" broiler network of more than 15,000 contract farmers taking the company's DOC and feed [4]. The company has described itself, plainly, as "the leading producer of animal feed" in the country [5].

The same integration reaches furthest downstream, where CPIN is most differentiated from its feed rivals. In processed chicken — the branded, higher-value end under Fiesta, Champ and Golden Fiesta — the company reported a market share of about 57%, an order of magnitude ahead of its feed-share lead [6]. Malindo, by contrast, positions itself as a "top-3 player in animal feed" whose core is the mill, with breeding and broilers built out around it [7]. Same industry, shallower chain.

The moat shows up in the margins

An advantage is only established if it appears in the numbers. It does. In FY2025 CPIN earned a gross margin near 17.6% and a net margin near 8.0% (net profit Rp5.64tn on sales of Rp70.70tn); Malindo, running the same feed inputs in the same market, earned a 10.2% gross margin and a 3.1% net margin (net profit Rp394bn on Rp12.69tn) [8] [9]. The gap is not a one-year artefact of mix — it is the return on scale and integration compounding through the chain.

Source: CPIN Q4 FY2025 income statement [10]; Malindo FY2025 results briefing [11].

The more telling contrast is directional. FY2025 was the year CPIN's downstream recovery drove group net profit up about 52% to a record (Downstream Cycle). In the very same year, Malindo's net profit fell 19.3%, as its thinner, feed-weighted mix was squeezed by higher raw-material costs it could not offset [12]. The same industry conditions produced a record for the leader and a decline for the number four. That is what scale-and-integration depth buys: the ability to turn a cyclical upswing into disproportionate profit while a sub-scale rival treads water.

Durability is the other half of the edge. CPIN has not reported a loss in any year of the FY2020–FY2025 cycle, its trough profit still Rp2.32tn in the brutal FY2023 downstream washout (Business and Cycle). That survivability rests on a balance sheet roughly three-quarters equity-funded with negligible net leverage, which let the company keep investing and paying dividends through the down-years (Cash Conversion). Malindo carries a materially heavier debt load — a history of bond issues and rights offerings, and single-digit EBITDA margins — the profile of an operator with far less room to absorb a bad year. In a cyclical commodity, the capacity to outlast the downturn is itself a competitive weapon, and it is CPIN's.

The controlling hand, and the CP group

CPIN is not an independent public company in the usual sense: the Jiaravanon family, founders of Thailand's Charoen Pokphand group, are its controlling shareholder, holding about 55.53% through a group vehicle [13]. The same family controls Charoen Pokphand Foods (CPF), the group's Bangkok-listed regional flagship and one of the world's largest integrated feed-to-food producers. CPF is a structural benchmark rather than a domestic rival — it operates across other Asian markets, not head-to-head with CPIN in Indonesia — but the relationship carries two implications an outside investor should hold. It gives CPIN access to group-wide breeding genetics, formulation know-how and procurement scale that a standalone Indonesian firm would lack. It also means a controlling owner sets capital allocation, related-party terms and the dividend, with public minorities along for the ride. The FY2025 payout discipline has been shareholder-friendly (Cash Conversion); the governance point is that it is a choice made by a controlling family, not a board answerable to a dispersed float.

Where the moat stops

The honest boundary of this moat is the downstream spread. CPIN's cost and integration edge protects the feed-and-breeding base — the stable layer that carried the whole company through FY2023. It does not protect the broiler cycle, because the live-bird price and the supply that sets it are managed at the industry level: government culling programmes, hatching-egg cuts and DOC placement policy move the spread for every integrator at once, CPIN included (Downstream Cycle). Market leadership does not exempt the leader from an oversupplied market; it only means CPIN loses less, and recovers faster, than the Malindos of the industry. The FY2023 trough — when even CPIN's downstream lost money — is the proof that share is not a spread hedge.

Two developments would test the read. New Hope and De Heus, both well-capitalised foreign feed groups, already hold a combined ~14% of feed capacity and are the credible source of share erosion at the margin; a sustained slide in CPIN's ~35% would signal the barrier is softening. And a durable convergence of CPIN's margins toward Japfa's or Malindo's — rather than the persistent gap seen today — would say the integration premium is narrowing. Neither is visible in the current data. On the evidence, the moat is wide in feed and breeding, narrow in the downstream — a genuine, quantified cost-and-integration advantage in the stable base, riding on a cyclical layer that no amount of market share can steady.

Pricing the Cycle

At Rp3,070 (15 July 2026) CPIN trades at 8.9 times record FY2025 earnings and 7.5 times the last twelve months — cheap for the market leader on the surface. But that low multiple sits on peak earnings. Normalise to the mid-cycle profit power the last decade actually delivered and the same price is roughly 11–14 times. The ~33% de-rating has moved the stock from pricing the peak toward pricing something nearer the average; it is neither the bargain the headline implies nor obviously expensive.

Share Price (Rp)

3,070

Market Cap (Rp bn)

50,342

P/E on Record EPS

8.9

P/E on Mid-Cycle EPS

13.7

Div Yield (FY2025 Rp180)

5.9%

Sources: share price and market data as of 16 July 2026; FY2025 net profit Rp5.64tn and EPS Rp344 [1]; dividend per share [2].

The company reported a record FY2025 net profit of Rp5.64tn, or Rp344 per share, on 16,398,000,000 shares [3] [4]. The valuation depends on which earnings number a buyer capitalises — and this business has swung from Rp141 per share in the FY2023 trough to Rp344 in FY2025 [5], a 2.4x range across three years.

What the multiple is capitalising

The chart below sets the last ten years of earnings per share against the two averages that bracket a reasonable mid-cycle: the six-year post-restatement mean (Rp224) and the ten-year mean (Rp213). FY2025's Rp344 sits about 55% above that mid-cycle band; the FY2023 trough sat about 37% below it.

Source: earnings per share FY2016–FY2025, derived from reported net profit attributable to owners and a constant 16,398,000,000 shares; FY2023–FY2025 figures per the Summary of Financial Highlights [6].

Constant shares across the decade make the EPS series a clean read on earning power — no dilution or buybacks distort it [7]. The pattern is the cycle the earlier chapters traced: a downstream-driven peak in FY2018 and FY2025, a trough in FY2023, and a feed-anchored floor that has never produced a loss year. What it is not is a smooth compounding line a single-multiple valuation would suit.

The multiple depends entirely on the denominator

Applying the Rp3,070 price to each plausible earnings base shows how wide the answer runs. On the record and trailing figures the stock looks visibly cheap; on any mid-cycle measure it is a full-to-fair multiple for a cyclical.

No Results

Sources: EPS bases derived from reported financials FY2016–FY2025 [8]; trailing and forward figures per market data and consensus estimates as of 16 July 2026.

The trailing multiple is the most misleading of the set. It reads 7.5x because the twelve months to Q1 2026 captured a further profit surge — Q1 2026 net profit rose to Rp2.58tn from Rp1.54tn a year earlier on higher chicken prices and volume. That is the top of the spread cycle feeding into the denominator, not a durable run-rate. The honest anchors are the mid-cycle rows: on the profit power the business has averaged since the FY2020 revenue restatement, Rp3,070 is about 11–14 times earnings.

Book value and returns give the same reading

A second lens removes the earnings-cyclicality problem by valuing the equity against its own book. CPIN carried Rp34.15tn of equity at year-end FY2025 — about Rp2,083 per share — so Rp3,070 is roughly 1.5 times book [9]. Against a FY2025 return on equity of 16.5%, 1.5x book implies a through-price earnings yield near 11% — the same order as the mid-cycle P/E, and consistent rather than contradictory.

Book Value / Share (Rp)

2,083

Price / Book

1.5

Return on Equity

17%

Source: shareholders' equity and return on equity, FY2023–FY2025 Summary of Financial Highlights [10].

The balance sheet also removes the leverage question a cyclical usually carries. CPIN sits on roughly Rp1.6tn of net cash, so enterprise value (about Rp48.7tn) is slightly below the equity market cap and an EV/EBITDA calculation would land close to the P/E reading rather than inflating it. There is no debt drag on the multiple — a point that matters more in a downturn, where a leveraged peer's equity multiple stretches as profit falls.

The income lens is softer than the headline. The FY2025 dividend of Rp180 per share, approved at the May 2026 AGM, is a 5.9% yield at Rp3,070 [11]. But the payout tracks cash, not a progressive commitment — it was Rp108 the year before (a 3.5% yield) and zero for FY2022 — so the yield is a by-product of a good year, not a floor to underwrite.

The de-rating in peer context

The clearest evidence that the market is repricing the cycle rather than the company is the divergence inside the sector. Over the twelve months to mid-July 2026 CPIN's market capitalisation fell about 34% (from roughly Rp76.4tn to Rp50.8tn) while Japfa Comfeed's rose about 41% (from Rp16.8tn to Rp23.7tn). The market narrowed CPIN's premium over its nearest integrated rival even as CPIN out-earned it — a rotation toward the cheaper, more downstream-levered name as the spread recovery matured, not a verdict on relative quality.

Source: market data, twelve-month change to 16 July 2026 (third-party market aggregators).

Two arm's-length marks sit well above spot. Sell-side consensus (11 analysts, a Buy skew) carries a mean 12-month target near Rp4,995, about 63% above Rp3,070; a published discounted-cash-flow estimate puts intrinsic value around Rp5,153, about 68% above. Both implicitly capitalise an earnings base nearer the record than the trough. That is the crux of the disagreement: the Street is valuing CPIN on sustained high-single-digit-billion profit, while the share price has drifted toward a mid-cycle number.

What the price implies, and what would decide it

Reduced to arithmetic: at Rp3,070 the market pays about 8.9x the record year and about 13x the ten-year average. Which of those is the right anchor is the same question the downstream and moat chapters left open — where the government-managed broiler spread settles once FY2026 normalises. If mid-cycle earning power holds near the Rp220–280 band the last decade delivered, the stock is fairly-to-fully valued around 11–14x and the ~33% de-rating was largely rational repricing of a peak. If the structural margin premium the leader has shown over peers (Competitive Moat) — an 8% net margin against Malindo's 3%, never a loss year — lifts the through-cycle average above history, then capitalising even Rp300 of normalised EPS at a market multiple leaves clear upside, which is where consensus and the DCF sit.

The strongest fact against reading today's price as cheap: the mid-cycle multiple is not low. A cyclical whose swing factor is set by government supply policy, trading at 13x its own ten-year average earnings with a variable dividend, is priced for the recovery to hold, not for distress. The strongest fact for the bull is quality-adjusted — this is the net-cash market leader earning a 16.5% ROE, and the cash-conversion work (Cash Conversion) confirmed the earnings are real money, not accrual.

The checkable items that resolve it are narrow and near. Reported broiler average selling prices and DOC placement volumes through 2026 are the direct read on whether the spread is normalising or oversupplying; the FY2026 result lands against the consensus Rp373 EPS on 31 July 2026; and the payout on FY2025-basis cash flags management's own read of durable earning power. Each is a line in the next filing, not a matter of opinion.

CPIN is 55.53%-controlled by the Jiaravanon family's Charoen Pokphand group, and the group is paid every year. The largest recurring channel is a brand royalty to a group entity in Singapore — Rp715bn in FY2025, up 15% since FY2022 and rising whether profits climb or fall [1]. It is disclosed, labelled arm's-length, and bounded at about 1% of sales — but it is a senior, pro-cyclical claim that minority holders own around, and it takes a far bigger bite of profit in a trough than at a peak.

Who controls the company

At 31 December 2025 one holder, PT Charoen Pokphand Indonesia Group, owned 9,106,385,410 shares — 55.53% of the 16,398,000,000 outstanding. UBS AG Singapore held 5.98% and the public float below 5% each accounted for 38.49% [2]. That parent sits under Thailand's Charoen Pokphand group, controlled by the Jiaravanon family; CPIN is its Indonesian listed vehicle (Competitive Moat).

Control runs through the board as well as the register. Indonesia's two-tier structure separates an executive Board of Directors from a supervisory Board of Commissioners, and CPIN's executive board carries no independent members; two of the four commissioners are independent [3]. The six directors are long-tenured insiders — the President Director, Tjiu Thomas Effendy, joined in 1980 — and the audit committee is chaired by an independent commissioner who spent 1976–2008 inside the company, latterly as VP Finance Controller. This is a controlled company by any definition; the governance question is not whether the family sets strategy but how much value moves to it outside the ordinary dividend, and whether that flow is fair.

The royalty

The clearest such flow is a brand-and-technology royalty. Since a 2009 license agreement — novated in 2017 to Nugen Bioscience International Pte. Ltd. of Singapore, an entity under common control with the CP group — CPIN has paid a royalty for the intellectual property behind its products [4]. In FY2025 the charge was Rp715bn, booked to general-and-administrative expense and equal to 30.9% of the group's total related-party expenses [5]. Around 1% of net sales leaves the consolidated group each year for the parent's brand.

The absolute number grows every year regardless of the cycle: Rp621bn in FY2022, Rp645bn in FY2023, Rp697bn in FY2024, Rp715bn in FY2025 [6] [7].

Source: Note 34/35 of the FY2023–FY2025 audited consolidated statements [8] [9] [10].

Because the royalty barely moves while pre-tax profit swings across the poultry cycle, its share of earnings is counter-cyclical to profit — largest when profit is smallest. The same Rp600–700bn was 9.3% of pre-tax profit in the record FY2025 but 21.5% in the FY2023 trough. For a business whose downstream spread is set by government supply policy rather than the company (Downstream Cycle), the royalty behaves like a fixed senior charge ahead of minority earnings, heaviest exactly when the cycle is against the reader.

Source: derived from the royalty note and consolidated pre-tax profit, FY2022–FY2025 audited statements [11] [12].

Two calibrations keep this in proportion. First, the royalty is a real economic input — the CP brand, breeding genetics, and technology are the same assets that underwrite the moat, so some payment for them is legitimate, not a pure transfer. Second, at roughly 1% of sales the charge is not large enough on its own to reset the investment case. What it does is lower the effective earnings minorities own by a near-fixed amount every year, and worsen the trough — a reason the mid-cycle multiple deserves a modest control discount rather than a clean read of reported EPS (Pricing the Cycle).

The recurring trade with the group

Beyond the royalty, CPIN buys raw materials from CP-affiliated suppliers in the ordinary course. In FY2025 these purchases totalled Rp3.28tn — 4.63% of net sales, up from Rp2.73tn (4.78%) in FY2024 — concentrated in a handful of common-control names [13].

No Results

Source: FY2025 audited consolidated statements, Note 34 — purchases of raw materials from entities under common control [14].

These are disclosed as priced on "agreed" terms, and each line is reported against its share of sales — but they are not independently repriced, so a slice of feed input cost is set within the group. At under 5% of sales the exposure is contained, and it has been stable as a proportion; the item to watch is whether that share climbs, which would move margin-setting further inside the family.

The one place related-party credit went wrong is small but instructive. CPIN carries Rp257bn of amounts due from group affiliates, of which Rp148bn is owed by PT Central Proteina Prima Tbk — CP's separately-listed shrimp arm — against which the group holds a Rp202bn allowance for impairment, essentially unchanged from FY2024 [15]. About four-fifths of the balance is written down and static, leaving Rp55bn net. Management states the allowance is adequate to cover non-collection [16]. The amount is immaterial to a Rp5.6tn-profit company, but it is a reminder that intra-group credit to a weaker CP affiliate can sit frozen on the balance sheet for years rather than being repaid or forgiven cleanly.

No Results

Sources: FY2025 audited consolidated statements, Note 34 [17] [18] [19] [20].

What does not leak

Three things a skeptic would reach for turn out to be benign, and saying so is part of an honest read.

The affiliated asset purchases look alarming until you read the counterparties. In FY2023 CPIN bought poultry slaughterhouses, land, and equipment across ten provinces for Rp374bn, plus Rp46bn of land — but the sellers (PT Mitra Sinar Jaya and five others) are its own 100%-indirectly-owned subsidiaries, so the transaction is an internal reorganization that nets out in consolidation, not a purchase from the parent [21]. In FY2025 the company disclosed no material and no conflict-of-interest transactions at all [22].

Trade-receivable credit quality is ordinary, not stretched. The allowance against third-party trade receivables is Rp284bn on Rp2.93tn gross — about 9.7%, and down slightly from FY2024 — with related-party trade receivables a trivial Rp15bn [23]. The plasma-farmer partnership model does not appear to be hiding an uncollectible book.

And key-management pay is modest for the size. Directors and commissioners were paid Rp189bn in gross compensation in FY2025, up 25.8% on FY2024 but still only about 3.4% of net profit, with no equity awards [24]. The controlling family is compensated mainly as a shareholder, through the dividend it receives pari passu with the float — roughly Rp1.6tn of the Rp2.95tn FY2025 declaration on its 55.53% stake — not through pay.

Pricing the control discount

The evidence points to a control structure that is real but restrained. The family sets strategy through a family-and-insider board, and it extracts a steady brand royalty of about 1% of sales that grows every year and bites hardest in the trough; beyond that, the disclosed leakage is bounded — ordinary-course purchases under 5% of sales, a small frozen affiliate receivable, modest pay, and pari-passu dividends. That profile argues for a modest discount to the mid-cycle multiple for governance, not the deep discount a genuine tunneling case would demand.

The strongest fact against a benign read is that none of the group flows are independently repriced: the royalty rate, the transfer prices on Rp3.3tn of purchases, and the terms of intra-group credit are all set inside a structure the family controls, and disclosure confirms the amounts without testing their fairness. What would change the read in either direction is observable in the same Note 34 each year — a step-up in the royalty beyond inflation, a rising related-party share of purchases, or a new large advance to a CP affiliate would signal value moving toward the parent; their continued stability would confirm that, so far, it is not.

The record did not stop with FY2025. Through the first quarter of 2026 — the freshest hard data in the file — net profit rose about 67% to Rp2.58tn on sales up 12.7%, led by day-old chicks (+77.6%) and feed (+28.4%) [1][2]. A ramping government meals programme underpins protein demand. The market's de-rating still bets this normalises; the observed evidence, so far, runs the other way.

The record extended, it did not roll over

Everything in this report to here has been retrospective — how CPIN earned its FY2025 result and what that result was worth. The through-line question is whether that year was a peak or durable earning power. The one place to test it directly is the data that has printed since: two quarters of 2026 results and the demand backdrop behind them.

The recovery kept going. Nine-month 2025 profit was already up 41.2% year on year [3]; the full year closed +52%. Then Q1 2026 net profit reached Rp2.58tn, up from Rp1.54tn a year earlier, on net sales of Rp19.95tn — a 12.7% top-line gain that the company attributes to both higher chicken prices and higher volume [4]. This is not a business reverting toward mid-cycle; it is one printing above the record it just set.

Q1 2026 net profit

Rp2.58 tn

Q1 2026 sales growth YoY

+12.7%

Q1 2026 DOC sales growth YoY

+77.6%

Source: Q1 FY2026 net sales by segment, Note 23 [5]; net-profit figure from company results as reported [6].

The segment mix tells the more useful story. CPIN's Q1 net sales by line make clear the 2026 acceleration is not broad-based — it is concentrated in exactly the parts of the chain that price off the spread the market worries about.

Source: Q1 FY2026 Consolidated Financial Statements, Note 23 Net Sales [7].

Broiler sales — the largest line — grew only 3.7%, and processed chicken was flat. The lift came from day-old chicks, up 77.6%, and feed, up 28.4%. Both are upstream of the finished bird: DOC prices lead the broiler cycle, and feed volume rises when farmers restock. A near-doubling of DOC revenue in one quarter is the clearest read that the sector was still tightening into 2026, not loosening — the same DOC-price strength that was the one downstream line to gain on price in the record year, now amplified. It builds directly on the efficiency-led recovery documented in Downstream Cycle, where FY2025's broiler result rose 64.89% to Rp3.35tn even as the average broiler selling price fell [8].

The demand side has a policy floor

The cyclical read has a structural companion that did not exist in prior troughs. Since 6 January 2025, Indonesia has run Makan Bergizi Gratis (MBG), a national free-nutritious-meals scheme championed by President Prabowo Subianto. It is not a small programme: the government allocated roughly Rp335tn (about US$21bn) to it for the current year, and realised spending reached Rp88.15tn by the end of May 2026 — up from Rp75tn a month earlier — feeding 48.9 million students and 14.3 million other beneficiaries through 29,679 kitchens (figures from Indonesia's Ministry of Finance and National Nutrition Agency; the government programme is not an issuer filing, so it is cited here as reported public data rather than a source PDF).

Chicken is a core protein in that meal plan, and the corpus shows the market has treated MBG as a genuine demand catalyst for poultry since late 2025 — sell-side and local coverage tied CPIN's Q3 2025 sector recovery to "rising broiler prices, tighter supply and MBG budget increase," and by January 2026 Vanguard and BlackRock had raised their stakes with MBG cited among the tailwinds [9]. Management's own framing is consistent: the FY2025 report attributes the farm-segment margin recovery to "more balanced supply-demand conditions and disciplined production planning," which "helped stabilise pricing and improve profitability" [10].

A ramping, budgeted demand programme is a different kind of support from a normal cyclical upswing. It gives the bull's normalised-earnings case — that FY2025 is closer to a new base than a peak — its first piece of forward, non-price evidence.

Three reasons the market is not convinced

The stock says otherwise. At Rp3,110 on 16 July 2026, CPIN trades near the lower end of its cyclical multiple range even as results accelerate — the anticipatory de-rating dissected in Pricing the Cycle. Three facts keep that scepticism honest.

First, MBG's translation into CPIN profit is asserted, not yet demonstrated. The programme has been a stock-narrative catalyst since 2024, and for its first year the narrative outran the numbers: in November 2024, coverage noted CPIN's profit and share price were weak despite the MBG programme (Bisnis.com, cited as public data). MBG procurement is decentralised across tens of thousands of local kitchens and spans eggs, fish and other proteins, not only broiler — how much of the Rp335tn actually flows to CPIN's product lines is nowhere quantified in the filings. The demand floor is real for the sector; CPIN's capture of it is unmeasured.

Second, the strength arrives with capex accelerating into it — the watch item from Cash Conversion. Capex re-accelerated to Rp1.70tn in FY2025 from a Rp0.76tn trough, and through 2025 the company kept expanding aggressively — a poultry breeding facility and a Rp430bn land-and-machinery purchase — even while it held to conservative full-year guidance [11]. Adding capacity at the top of a spread cycle is the classic way integrators convert a good year into the next glut; the timing is a risk precisely because current conditions are good.

Third, the recovery is not a rising tide. In the same FY2025 that CPIN set a record, PT Widodo Makmur Unggas — a smaller, downstream-heavy integrator — booked a net loss of Rp83bn on sales of Rp741bn, citing "weakening purchasing power," higher feed-input costs, and "DOC and livebird price fluctuation" [12]. The favourable 2026 setup rewards scale and integration; it does not lift everyone, which means the "sector recovery" is thinner than the headlines and more dependent on CPIN's own cost position than on a broad demand wave.

What would settle it

The observed data through Q1 2026 favours durability over reversion, but the quarter carries a seasonal Ramadan lift and one strong quarter does not make a base. Three checks over the rest of 2026 would move the read in either direction. Whether broiler selling prices hold through the second half — not the DOC and restocking strength that led Q1, but the finished-bird price that drives the largest segment — is the cleanest test of whether the spread has a floor or is topping. Whether MBG's realised spend keeps climbing toward its Rp335tn allocation, and whether any of it shows up as a broiler or processed-chicken volume line rather than sector sentiment, would convert the demand story from asserted to measured. And whether the FY2025 capacity additions arrive into firm or softening prices will show, within a year or two, whether the capex was well-timed or the seed of the next down-leg. Until those print, the record stands extended, and the discount rests on the assumption that it cannot last.

Scenarios and Signposts

The eight chapters before this one priced CPIN's parts in isolation. Read together, the case is most sensitive to a single arithmetic choice — which earnings figure belongs under the Rp3,070 price — and it has three plausible answers. At the record FY2025 base the stock is cheap; at the mid-cycle earnings the last decade actually delivered it is roughly fair; at a downstream trough it is dear. The pivot across all three is the broiler spread CPIN does not set, and the market, at 8.9x the record, already prices the middle answer.

The denominator carries the debate

The valuation argument depends on which earnings number belongs under the price. CPIN earned a record Rp5.64tn net profit in FY2025, or Rp344 per share [1]. But the same per-share line has printed Rp141 in the FY2023 trough and averaged about Rp224 across the last six years — a 2.4x span between the low and the peak. At Rp3,070 the stock is 8.9x the record, 7.5x an inflated trailing figure, and 11–14x the mid-cycle earnings the business has actually generated.

Source: FY2025 EPS Rp344 as reported [1]; trough, average, and normalized bases derived from reported FY2020–FY2025 financials (Pricing the Cycle).

The record was efficiency-driven, not a price spike — the broiler segment's result rose 64.9% even as its average selling price fell [2], and processed chicken swung from a Rp0.08tn loss to a Rp0.86tn profit on lower cost of goods [3]. Efficiency can persist, which makes the record higher-quality than a spot-price windfall. But the level still sits on an industry spread that put the same broiler line into a loss in FY2023, when feed alone produced 104% of the group's segment result and the downstream lost money [4]. Which basis is right decides whether the ~33% de-rating from the January 2026 high is an opportunity or a correct call.

Three scenarios, one variable

The scenarios below hold the framework simple: an earnings basis, a valuation method matched to it, and a resulting fair-value range. All three apply the same modest control-and-royalty discount established in Control and Related Parties — a 12–13x multiple rather than the 13–14x the market historically paid the average earnings, reflecting the near-fixed Rp715bn brand royalty [5] and a family-controlled structure whose intra-group terms are disclosed but not independently repriced.

Current price Rp3,070 (15 Jul 2026) sits at the mid-cycle midpoint. Source: derived from reported FY2020–FY2025 financials and book value (Pricing the Cycle); scenario framework as described.

No Results

Source: derived from reported financials — FY2025 segment results [6], equity of Rp34.15tn (book value Rp2,083/share) [7]; scenario framework and multiples as described.

Reverts to mid-cycle is the neutral. Applying 12–13x to the Rp224–276 the business earns on average puts fair value at roughly Rp2,700–3,600 — a band whose midpoint, near Rp3,150, is within a few percent of where the shares trade. The de-rating has repriced the stock from the peak toward the average, not to a discount against normalized value.

Spread holds elevated is the bull, and it is where consensus sits: capitalize a base near the record or trailing figure and fair value runs to about Rp4,100–5,300, bracketing the ~Rp4,995 one-year consensus and the street's higher DCF-based marks near Rp5,900. This requires two things to hold together — the FY2025 efficiency gains proving durable, and the demand floor from the government's Free Nutritious Meals (MBG) programme translating into CPIN volume. Q1 2026 net profit of Rp2.58tn, up about 67%, is consistent with the base extending [8], though the growth was concentrated upstream — day-old chicks up 77.6% and feed up 28.4% against broiler up only 3.7% [9], and Q1 carries a Ramadan lift.

Downstream troughs is the bear. If oversupply returns and the downstream reverts to loss as it did in FY2023, per-share earnings fall toward Rp141 and the stock is better valued off book than off a depressed multiple: at 1.0–1.2x the Rp2,083 book value, roughly Rp2,100–2,500, or about 19–32% below spot. The downside is real but cushioned — CPIN has posted no loss year since FY2020 and runs a net-cash balance sheet [10]. The offsetting risk is that a trough compresses the book itself: biological assets plus inventories are Rp16.65tn, about 36% of total assets, and are carried on the same cyclical chicken and feed prices [11].

On the numbers the payoff is asymmetric toward the upside — roughly +34% to +73% if the elevated base holds against about −19% to −32% if the spread troughs, with the neutral outcome near today's price. The weighting, though, rests on the forward broiler spread, which the filings cannot show, and the one new structural support the bull leans on is real in aggregate but unquantified for CPIN: the MBG programme had realized about Rp88.15tn of a Rp335tn budget by end-May 2026, yet no CPIN disclosure ties any revenue to it, and in November 2024 the shares were weak with MBG already a talking point. What would move the read is direct: a live-bird price that sustains above the government reference floor, and a first disclosed MBG-linked revenue line.

The tension, as shared facts

Each row is a fact both sides accept; they disagree on what it implies and on what would settle it.

No Results

Sources: FY2025 broiler result and pricing [2]; Q1 2026 segment detail [9]; FY2023 trough segments [4]; FY2025 capex [12]. MBG figures per Indonesia's National Nutrition Agency, as reported.

The rows are not symmetric. Feed is the settled part of the case — a cross-cycle earner that has never posted a loss year — and it makes the downside survivable rather than existential (Feed Economics). The moat is proven where it operates, in an 8.0% net margin against Malindo's 3.1% in the same year (Competitive Moat), but it protects the stable feed and breeding base, not the government-managed downstream spread. The recovery is also not universal: peer PT Widodo Makmur Unggas booked a FY2025 net loss on weak purchasing power [13], a reminder that scale and integration, not sector membership, earned CPIN's result.

What to watch

Each item names a line, where it prints, the threshold that changes the read, and which way a surprise cuts.

No Results

Sources: feed floor and segment results [6]; FY2025 capex [12]; royalty [5]; FY2025 dividend of Rp2.95tn / Rp180 per share [14]. Live-bird price and MBG figures per government and program data, as reported.

The single most useful of these is the first: the farm-gate live-bird price against the government's reference. It is the direct reading of the spread that the segment revenue lines can only proxy, it prints weekly rather than quarterly, and it is the variable that moves the earnings basis — and therefore the scenario — more than any other. The debate does not resolve in the filings; it resolves in that price.

Generated Jul 16, 2026 13:47 UTC